Bimatoprost
Back to searchMolecule Structure
Scientific Name
Bimatoprost
Description of the Drug
Bimatoprost is a prostaglandin analog used to treat hypotrichosis of the eyelashes and intraocular pressure in open angle glaucoma or ocular hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00905
http://www.drugbank.ca/drugs/DB00905
Brand Name(s)
Bimatoprost, Durysta, Latisse, Lumigan
Company Owner(s)
Micro Labs Ltd, Apotex Inc, Somerset Therapeutics Llc, Alembic Pharmaceuticals Ltd, Sandoz Inc, Gland Pharma Ltd, Allergan Inc, Akorn Operating Co Llc, Lupin Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Prostanoid FP receptor | SINGLE PROTEIN | AGONIST | CHEMBL1987 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL24425 | |||
| PharmGKB | PA164748867 | |||
| Human Metabolome Database | HMDB0015041 | |||
| DrugBank | DB00905 | |||
| PubChem: Thomson Pharma | 14855657 | 14880018 | ||
| PubChem | 5311027 | |||
| Nikkaji | J1.596.089B | |||
| PDBe | 15M | |||
| BindingDB | 220120 | |||
| EPA CompTox Dashboard | DTXSID30895042 | |||
| DrugCentral | 371 | |||
| Brenda | 27704 | 154363 | 153380 | 13626 |
| ChemicalBook | CB0171421 | |||
| Guide to Pharmacology | 1958 | |||
| rxnorm | BIMATOPROST | LATISSE | LUMIGAN | DURYSTA |
| PubChem: Drugs of the Future | 12015127 | |||
| ChEBI | 51230 | |||
| ZINC | ZINC000004474405 |
